Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Neurocrine Bioscienc (NBIX)

92.14 0.47 (0.51%)

05-22 09:50

Open:

91.79

Pre. Close:

91.67

High:

92.92

Low:

91.79

Volume:

9,541

Market Cap:

8283M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

94.439 - 94.915

94.915 - 95.306

Low:

89.631 - 90.125

90.125 - 90.531

Close:

90.943 - 91.721

91.721 - 92.36

Technical analysis  (as of: 2018-05-21 4:31:46 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 110.35     One year: 128.89

Support:

Support1: 82.94    Support2: 75.80

Resistance:

Resistance1: 94.48    Resistance2: 110.35

Pivot:

87.64

Moving Averages:

MA(5): 92.84     MA(20): 85.67

MA(100): 83.39     MA(250): 67.85

MACD:

MACD(12,26): 3.27     Signal(12,26,9): 2.38

%K %D:

%K(14,3): 88.82     %D(3): 92.14

RSI:

RSI(14): 63.68

52-Week:

High: 94.48  Low: 41.76  Change(%): 71.2

Average Vol(K):

3-Month: 77860  10-Days 68470

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
NBIX has closed below upper band by 28.8%. Bollinger Bands are 52.8% wider than normal. The large width of the bands suggest high volatility as compared to NBIX's normal range. The bands have been in this wide range for 4 bars. This is a sign that the current trend might continue.

Headline News

2018-05-14T11:37:23-04:00
JF's Core Biotech Buys #15: Removal Of A Key Overhang, Buying Weakness In I-O, Updates And Adding To 2 Positions

2018-05-09T16:01:00-04:00
Neurocrine Biosciences to Present at the Bank of America Merrill Lynch 2018 Healthcare Conference

2018-05-08T15:02:53-04:00
Lucky Seven: Omeros Moves, Array Biopharma May Be Next

2018-05-08T14:00:00-04:00
Neurocrine Biosciences Presents New Quality of Life Data from RE-KINECT, the Largest Real-World Screening Study of Possible Tardive Dyskinesia in Patients Treated with Antipsychotics

2018-05-07T15:40:31-04:00
JF's Core Biotech Buys #14: Introducing Our Final 2 Positions & Taking Advantage Of Weakness In The I-O Space

2018-05-03T05:28:00-04:00
Lucky Seven: An Introduction To My Top Biotechnology Picks

2018-05-02T16:14:00-04:00
Neurocrine Biosciences to Present New Data from RE-KINECT, the Largest Real-World Screening Study of Possible Tardive Dyskinesia Patients, at the 2018 American Psychiatric Association Annual Meeting

2018-05-01T13:16:14-04:00
Neurocrine Reaping The Benefits Of A Methodical Approach

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

89.90

Shares Float (M)

87.94

% Held by Insiders

2.20

% Held by Institutions

Shares Short (K)

6132

Shares Short Prior Month (K)

8380

Stock Financials

EPS

-1.210

EPS Est. Current Year

-2.450

EPS Est. Next Year

-1.700

EPS Est. Next Quarter

-0.410

Forward EPS

1.830

Book Value (p.s.)

21.660

PEG Ratio

-4.21

Profit Margin

-45.56

Operating Margin

-81.28

Return on Assets (ttm)

-19.4

Return on Equity (ttm)

-34.7

Qtrly Rev. Growth

Gross Profit (p.s.)

1.784

Sales Per Share

EBITDA (p.s.)

-0.476

Qtrly Earnings Growth

Operating Cash Flow (M)

-94.33

Levered Free Cash Flow (M)

-56.42

atoplab.com

Valuation

P/E

-75.76

P/E Growth Ratio

-0.02

P/BV

4.23

P/S

4478876672.00

P/CF

-87.36

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

1995-12-29

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.